Terms: = Liver cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Diagnosis
428 results:
1. An assessment of risk factors for recurrence and survival for patients undergoing liver resection for intrahepatic cholangiocarcinoma.
Öztürk NB; Jamil LH
Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):766-774. PubMed ID: 38683193
[TBL] [Abstract] [Full Text] [Related]
2.
Lucas MR; Atkins JL; Pilling LC; Shearman JD; Melzer D
BMJ Open; 2024 Mar; 14(3):e081926. PubMed ID: 38479735
[TBL] [Abstract] [Full Text] [Related]
3. Classification and Diagnostic Prediction of Colorectal cancer Mortality Based on Machine Learning Algorithms: A Multicenter National Study.
Mohammadi G; Azizmohammad Looha M; Pourhoseingholi MA; Rezaei Tavirani M; Sohrabi S; Zareie Shab Khaneh A; Piri H; Alaei M; Parvani N; Vakilzadeh I; Javadi S; Moradian Haft Cheshmeh Z; Razzaghi Z; Robati RM; Zamanian Azodi M; Zarean Shahraki S; Hadavi M; Talebi R; Yazdani JC; Motlagh ME; Khodakarim S
Asian Pac J Cancer Prev; 2024 Jan; 25(1):333-342. PubMed ID: 38285801
[TBL] [Abstract] [Full Text] [Related]
4. Avoiding lead-time bias by estimating stage-specific proportions of cancer and non-cancer deaths.
Chang ET; Clarke CA; Colditz GA; Kurian AW; Hubbell E
Cancer Causes Control; 2024 May; 35(5):849-864. PubMed ID: 38238615
[TBL] [Abstract] [Full Text] [Related]
5. Minimally invasive liver resection for cholangiolocellular carcinoma: A single-institution experience.
Kihara Y; Takeda Y; Ohmura Y; Katsura Y; Shinke G; Kinoshita M; Aoyama S; Yanagisawa K; Katsuyama S; Ikeshima R; Hiraki M; Sugimura K; Masuzawa T; Hata T; Murata K
Asian J Endosc Surg; 2024 Jan; 17(1):e13272. PubMed ID: 38212270
[TBL] [Abstract] [Full Text] [Related]
6. Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and liver Metastasis: A Total Population Analysis from 2006 to 2021 in Germany.
Thoduka SG; Flegar L; Groeben C; Huber J; Eisenmenger N; Paulus T; Vogt K; Luster M; Abolmaali N
Curr Oncol; 2023 Dec; 30(12):10325-10335. PubMed ID: 38132386
[TBL] [Abstract] [Full Text] [Related]
7. Prediction of survival and analysis of prognostic factors for hepatocellular carcinoma: a 20-year of imaging diagnosis in Upper Northern Thailand.
Nakharutai N; Chitapanarux I; Traisathit P; Srikummoon P; Pojchamarnwiputh S; Inmutto N; Na Chiangmai W
BMC Cancer; 2023 Nov; 23(1):1063. PubMed ID: 37923991
[TBL] [Abstract] [Full Text] [Related]
8. Association of the age of onset of metabolic syndrome with the risk of all cancer types.
Liu T; Liu CA; Zhang QS; Zhang Q; Wang YM; Song MM; Lin SQ; Deng L; Wu SL; Shi HP
Diabetes Metab Syndr; 2023 Nov; 17(11):102896. PubMed ID: 37913630
[TBL] [Abstract] [Full Text] [Related]
9. Clinical characteristics of hepatocellular carcinoma in patients with cirrhosis: a comparative cohort study.
Kaze E; Henrion J
Acta Gastroenterol Belg; 2023; 86(3):412-416. PubMed ID: 37814557
[TBL] [Abstract] [Full Text] [Related]
10. Regional variation in routes to diagnosis of cholangiocarcinoma in England from 2006 to 2017.
Zalin-Miller A; Jose S; Knott C; Paley L; Tataru D; Morement H; Toledano MB; Khan SA
World J Gastroenterol; 2023 Jun; 29(24):3825-3842. PubMed ID: 37426314
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of ultrasonographic images using a deep learning-based model as ancillary diagnostic tool for diagnosing gallbladder polyps.
Choi JH; Lee J; Lee SH; Lee S; Moon AS; Cho SH; Kim JS; Cho IR; Paik WH; Ryu JK; Kim YT
Dig Liver Dis; 2023 Dec; 55(12):1705-1711. PubMed ID: 37407319
[TBL] [Abstract] [Full Text] [Related]
12. Disparities in hepatocellular carcinoma survival by Medicaid-status: A national population-based risk analysis.
Kim EJ; Ganga A; Lee JY; Zawadzki RS; Adriance W; Wang R; Cholankeril G; Somasundar PS
Eur J Surg Oncol; 2023 Apr; 49(4):794-801. PubMed ID: 36503726
[TBL] [Abstract] [Full Text] [Related]
13. Recent trends in the incidence and survival of stage I liver cancer: a surveillance, epidemiology, and end results analysis.
Yu XC; Liu JB; Tang QH; Diao X; Fan QY; Huang ZY; Tang XM; Li S; Cao YF; Ma YS; Fu D
Ann Med; 2022 Dec; 54(1):2785-2795. PubMed ID: 36370068
[TBL] [Abstract] [Full Text] [Related]
14. All-cause and liver-related mortality risk factors in excessive drinkers: Analysis of data from the UK biobank.
Whitfield JB; Seth D; Morgan TR;
Alcohol Clin Exp Res; 2022 Dec; 46(12):2245-2257. PubMed ID: 36317527
[TBL] [Abstract] [Full Text] [Related]
15. Incidence and Survival in Synchronous and Metachronous liver Metastases From Colorectal cancer.
Reboux N; Jooste V; Goungounga J; Robaszkiewicz M; Nousbaum JB; Bouvier AM
JAMA Netw Open; 2022 Oct; 5(10):e2236666. PubMed ID: 36239935
[TBL] [Abstract] [Full Text] [Related]
16. Risk of nonalcoholic fatty liver disease and associations with gastrointestinal cancers.
McHenry S; Zong X; Shi M; Fritz CDL; Pedersen KS; Peterson LR; Lee JK; Fields RC; Davidson NO; Cao Y
Hepatol Commun; 2022 Dec; 6(12):3299-3310. PubMed ID: 36221229
[TBL] [Abstract] [Full Text] [Related]
17. Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality.
Kim HS; Xiao X; Byun J; Jun G; DeSantis SM; Chen H; Thrift AP; El-Serag HB; Kanwal F; Amos CI
JAMA Netw Open; 2022 Oct; 5(10):e2234221. PubMed ID: 36190732
[TBL] [Abstract] [Full Text] [Related]
18. Improved survival of viral hepatocellular carcinoma but not non-viral hepatocellular carcinoma from 2000 to 2020: A multi-centre cohort study of 6007 patients from high-volume academic centres in Japan.
Toyoda H; Kariyama K; Hiraoka A; Tsuji K; Ishikawa T; Hatanaka T; Naganuma A; Yasuda S; Nouso K; Kakizaki S; Kumada T; Innes H; Johnson PJ
Aliment Pharmacol Ther; 2022 Aug; 56(4):694-701. PubMed ID: 35707936
[TBL] [Abstract] [Full Text] [Related]
19. Childhood cancer survival and avoided deaths in Australia, 1983-2016.
Youlden DR; Baade PD; Moore AS; Pole JD; Valery PC; Aitken JF
Paediatr Perinat Epidemiol; 2023 Jan; 37(1):81-91. PubMed ID: 35672573
[TBL] [Abstract] [Full Text] [Related]
20. The prognosis of elderly patients with hepatocellular carcinoma: A multi-center 19-year experience in Japan.
Hatanaka T; Kakizaki S; Hiraoka A; Kariyama K; Tsuji K; Ishikawa T; Toyoda H; Yasuda S; Naganuma A; Tada T; Takaguchi K; Tsutsui A; Itobayashi E; Shimada N; Shibata H; Tanaka T; Nagano T; Imai M; Nakamura S; Nouso K; Kosaka H; Kaibori M; Kumada T;
Cancer Med; 2023 Jan; 12(1):345-357. PubMed ID: 35608226
[TBL] [Abstract] [Full Text] [Related]
[Next]
